Mission.

The mission consists of transforming and modernizing the GMP/GDP Management Review process within a pharmaceutical environment, evolving it from a primarily compliance-driven and retrospective exercise into a forward-looking, proactive, and insight-driven governance framework.

The role focuses on strengthening Quality Management System (QMS) governance, improving visibility on quality system performance, and enhancing the connection between operational quality indicators, patient safety, portfolio risks, and enterprise decision-making.

Beyond GMP/GDP activities, the objective is to support a broader Quality Transformation program, with future expansion across additional domains such as Clinical, R&D, Development, and Pharmacovigilance.

The goal is to enable the organization to improve quality governance maturity, strengthen strategic oversight, and support data-driven quality decision-making